PNS4 The Consequences of Greater Net Price Transparency for Innovative Medicines: Insights from European Experts and Payers

Autor:	M. Pistollato, H. Ahir, K. Ross-Stewart
Rok vydání:	2021
Předmět:	business.industry Health Policy Public Health Environmental and Occupational Health Accounting Business Transparency (behavior)
Zdroj:	Value in Health. 24:S173
ISSN:	1098-3015
DOI:	10.1016/j.jval.2021.04.859
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9af4816b03c9808b42349384d8beb3f2 https://doi.org/10.1016/j.jval.2021.04.859 Zobrazit plný text záznamu Full Text from ScienceDirect